Flu Vaccine Cut Risk for Influenza-Linked Hospitalizations in 2023
Interim data show vaccine effectiveness of 51.9 percent in five South American countries during their flu season
FDA Approves New COVID-19 Booster Shots
New booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating
Gefapixant Leads to Modest Improvements in Cough
Modest improvement seen in cough frequency, severity, and specific quality of life, but increase seen in treatment-, taste-related adverse events
Risk for Death, Cardiovascular Death Lower for OSA Patients Using CPAP
Reduction seen in low-density coronary artery plaque volume with CPAP and with use of CPAP and GLP-1-mediated weight loss
Increase Seen in COPD Hospital Admissions Since 2010 in Canada
Age-standardized rates increased among younger women and men and older women, while they declined in older men
Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use
Hypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
Population attributable risk percentage for antepartum anemia and SMM highest for multiracial, Black, Hispanic patients
Linguistic Disparities Impact Patient Access to Cancer Care
Non-English-speaking patient callers to hospital are less likely to be provided with next steps to access cancer care
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
Age-adjusted mortality rate increased for men versus women and Black versus White patients
Providers Have Inadequate Awareness of PCV20 Vaccination Recommendations
Two-thirds of health care providers agree with expanding recommendations for new PCV20
